Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 97 results found. Search for [ essential%20drugs ]

Results 80 to 97 of 97
www.businesstoday.in
New Delhi, May 16, 2013
Prices of 348 medicines, including life saving drugs, will be cheaper soon by up to 80 per cent as the new Drug Price Control Order has come into effect.


www.businesstoday.in
January 2, 2013
Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon Ltd, and the face of India's flowering biotechnology industry, pulls no punches in this exclusive interview to Govindraj Ethiraj on the show Bottomline, aired on Headlines Today. Edited excerpts:


www.businesstoday.in
New Delhi, December 25, 2012
A new drug price control policy, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the $22 billion pharmaceutical sector.


www.businesstoday.in
New Delhi, December 13, 2012
The National Pharmaceutical Pricing Policy 2012, which was cleared by the government in November, would bring 348 essential drugs under price control.


www.businesstoday.in
New Delhi, December 4, 2012
harmaceutical industry on Tuesday criticised the government's decision to make it mandatory for all foreign investments in existing domestic pharma firms to be cleared by the FIPB.


www.businesstoday.in
New Delhi, December 3, 2012
Every proposal for foreign investment in existing Indian pharmaceutical companies will go to the Foreign Investment Promotion Board till the time the Competition Act is amended.


www.businesstoday.in
New Delhi, November 24, 2012
The National Pharmaceutical Pricing Policy approved by the Cabinet on Thursday could bring only little relief to patients in terms of price reduction because cheaper brands could turn costly. In addition, many drugs remain out of the price control mechanism.


www.businesstoday.in
November 23, 2012
Under the terms of the policy, prices of 348 essential drugs will be based on the simple average price of all brands within a category that have at least one per cent market share.


www.businesstoday.in
New Delhi, November 22, 2012
The National Pharmaceutical Pricing Policy has been approved by the Cabinet with an objective to put in place a regulatory framework for pricing of drugs to ensure their availability at reasonable prices.


www.businesstoday.in
November 3, 2012
The UPA govt has told the SC that it will frame a new policy for pricing essential drugs by end-November. Currently, only 74 drugs are under price control. The government now wants to bring all the 348 drugs under the National List of Essential Medicines under price control.


www.businesstoday.in
Berlin, May 10, 2012
Bayer holds the patent for Nexavar till 2020 and it will \"vigorously defend its patent within the available legal framework\".


www.businesstoday.in
May 7, 2012
Always carry a first-aid kit and take out medical insurance when you travel.


www.businesstoday.in
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?


www.businesstoday.in
New Delhi, January 4, 2011
The Government is expected to soon take a call on slashing the foreign direct investment limit in the pharmaceutical sector in order to bring down the prices of drugs.


www.businesstoday.in
New Delhi, December 28, 2010
Drug firm Cipla on Tuesday said it has received fresh notices from National Pharmaceutical Pricing Authority (NPPA) for Rs 73.16 crore for overpricing of two drugs.


www.businesstoday.in
May 11, 2009
Find out about the exclusions in your cover to ensure smooth settlement of claims.


www.businesstoday.in
January 23, 2008
Like IT, most pharma funds have underperformed in a booming market. What should the investor do right now — sell, hold or buy? Here are some answers.


www.businesstoday.in
August 29, 2007
Generic drugs will continue to dominate the Indian pharma market over the next five years, but multinational companies are lobbying to shape patent laws to protect their profitability over the long term. How far will they succeed?


PAGES 5 OF 5  12345